Bendamustine hydrochloride monotherapy or combination therapy has been designated by European and American clinical guidelines as a first - or second-line treatment option for a variety of hematological malignancies
CAS Number
3543-75-7
Solubility
H2O: >30mg/mL
Storage
room temp
Applications
Treatment of Chronic Lymphocytic Leukemia (CLL)
Melting Point
149-151°C
EC Number
631-540-0
Molecular Weight (g/mol)
394.72
Physical State
powder
Color
off-white
Online Inquiry
Please note: Our products and services are not intended to be used directly in diagnostic or therapeutic procedures.
Close
GET IN TOUCH
Enter your email here to subscribe.
Easy access to products and services you need from our library via powerful searching tools.